These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26316738)

  • 1. A variant in 3'-untranslated region of KRAS compromises its interaction with hsa-let-7g and contributes to the development of lung cancer in patients with COPD.
    Hu H; Zhang L; Teng G; Wu Y; Chen Y
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1641-9. PubMed ID: 26316738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single nuclear polymorphism in let-7g binding site affects the doubling time of thyroid nodule by regulating KRAS-induced cell proliferation.
    Liu A; Zhang W; Zhao T; Xiao M; Mei Q; Zhu H
    J Cell Physiol; 2019 Dec; 234(12):23437-23447. PubMed ID: 31152438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single nucleotide polymorphism in the 3'-untranslated region of the KRAS gene disrupts the interaction with let-7a and enhances the metastatic potential of osteosarcoma cells.
    Zhang S; Hou C; Li G; Zhong Y; Zhang J; Guo X; Li B; Bi Z; Shao M
    Int J Mol Med; 2016 Sep; 38(3):919-26. PubMed ID: 27430246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer.
    Huang X; Yang Y; Guo Y; Cao ZL; Cui ZW; Hu TC; Gao LB
    Genet Mol Res; 2015 Dec; 14(4):16913-20. PubMed ID: 26681038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A let-7 binding site polymorphism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer.
    Li ZH; Pan XM; Han BW; Guo XM; Zhang Z; Jia J; Gao LB
    Tumour Biol; 2013 Oct; 34(5):3159-63. PubMed ID: 23729275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk.
    Chin LJ; Ratner E; Leng S; Zhai R; Nallur S; Babar I; Muller RU; Straka E; Su L; Burki EA; Crowell RE; Patel R; Kulkarni T; Homer R; Zelterman D; Kidd KK; Zhu Y; Christiani DC; Belinsky SA; Slack FJ; Weidhaas JB
    Cancer Res; 2008 Oct; 68(20):8535-40. PubMed ID: 18922928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A let-7 microRNA binding site polymorphism in the KRAS 3'UTR is associated with increased risk and reduced survival for gallbladder cancer in North Indian population.
    Kazmi HR; Chandra A; Kumar S; Satyam LK; Gupta A; Nigam J; Srivastava M; Mittal B
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2577-2583. PubMed ID: 27620744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer.
    Xiong F; Wu C; Chang J; Yu D; Xu B; Yuan P; Zhai K; Xu J; Tan W; Lin D
    Cancer Res; 2011 Aug; 71(15):5175-81. PubMed ID: 21676885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A let-7 KRAS rs712 polymorphism increases colorectal cancer risk.
    Pan XM; Sun RF; Li ZH; Guo XM; Zhang Z; Qin HJ; Xu GH; Gao LB
    Tumour Biol; 2014 Jan; 35(1):831-5. PubMed ID: 23975373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single nucleotide polymorphism in 3' untranslated region of epithelial growth factor receptor confers risk for pulmonary hypertension in chronic obstructive pulmonary disease.
    Zhou S; Li M; Zeng D; Xu X; Fei L; Zhu Q; Zhang Y; Wang R
    Cell Physiol Biochem; 2015; 36(1):166-78. PubMed ID: 25925667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis.
    Schneiderova M; Naccarati A; Pardini B; Rosa F; Gaetano CD; Jiraskova K; Opattova A; Levy M; Veskrna K; Veskrnova V; Buchler T; Landi S; Vodicka P; Vymetalkova V
    Mutagenesis; 2017 Oct; 32(5):533-542. PubMed ID: 29048575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MicroRNA hsa-let-7g Promotes Proliferation and Inhibits Apoptosis in Lung Cancer by Targeting HOXB1.
    Cui F; Zhou Q; Xiao K; Ma S
    Yonsei Med J; 2020 Mar; 61(3):210-217. PubMed ID: 32102121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between let-7 binding site polymorphism rs712 and risk of nasopharyngeal carcinoma.
    Pan XM; Jia J; Guo XM; Li ZH; Zhang Z; Qin HJ; Xu GH; Gao LB
    Fam Cancer; 2014 Mar; 13(1):93-7. PubMed ID: 23996697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive sequence variation in the 3' untranslated region of the KRAS gene in lung and ovarian cancer cases.
    Kim M; Chen X; Chin LJ; Paranjape T; Speed WC; Kidd KK; Zhao H; Weidhaas JB; Slack FJ
    Cell Cycle; 2014; 13(6):1030-40. PubMed ID: 24552817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of Microrna-126 Contributes to Tumorigenesis of Squamous Tongue Cell Carcinoma via Targeting KRAS.
    Han J; Wang L; Wang X; Li K
    Med Sci Monit; 2016 Feb; 22():522-9. PubMed ID: 26883054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant association between Let-7-KRAS rs712 G > T polymorphism and cancer risk in the Chinese population: a meta-analysis.
    Du XY; Hu YY; Xie C; Deng CY; Liu CY; Luo ZG; Niu YM; Shen M
    Oncotarget; 2017 Feb; 8(8):13863-13871. PubMed ID: 28099923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association analysis of miRNA-related genetic polymorphisms in miR-143/145 and KRAS with colorectal cancer susceptibility and survival.
    Wang D; Liu Q; Ren Y; Zhang Y; Wang X; Liu B
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33825830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted knock-in of the polymorphism rs61764370 does not affect KRAS expression but reduces let-7 levels.
    Crowley EH; Arena S; Lamba S; Di Nicolantonio F; Bardelli A
    Hum Mutat; 2014 Feb; 35(2):208-14. PubMed ID: 24282149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study of the let-7 miRNA-complementary site variant in the 3' untranslated region of the KRAS gene in stage III colon cancer (NCCTG N0147 Clinical Trial).
    Sha D; Lee AM; Shi Q; Alberts SR; Sargent DJ; Sinicrope FA; Diasio RB
    Clin Cancer Res; 2014 Jun; 20(12):3319-27. PubMed ID: 24727325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetic variation in microRNA target site of KRT81 gene is associated with survival in early-stage non-small-cell lung cancer.
    Lee SY; Choi JE; Jeon HS; Hong MJ; Choi YY; Kang HG; Yoo SS; Lee EB; Jeong JY; Lee WK; Lee J; Cha SI; Kim CH; Kim YT; Jheon S; Son JW; Park JY
    Ann Oncol; 2015 Jun; 26(6):1142-1148. PubMed ID: 25716425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.